Francesco Calderaro

542 total citations
12 papers, 408 citations indexed

About

Francesco Calderaro is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Francesco Calderaro has authored 12 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in Francesco Calderaro's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (6 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Francesco Calderaro is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (6 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Francesco Calderaro collaborates with scholars based in Italy, Argentina and Japan. Francesco Calderaro's co-authors include Mario Cazzola, F. Di Perna, Maria Gabriella Matera, Antonello Salzillo, Francesco Imperatore, Annamaria Vinciguerra, Stefano Centanni, R. Testi, Gabriele Di Lorenzo and Paolo Tini and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Journal of Cellular Biochemistry.

In The Last Decade

Francesco Calderaro

11 papers receiving 386 citations

Peers

Countries citing papers authored by Francesco Calderaro

Since Specialization

Citations

This map shows the geographic impact of Francesco Calderaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Calderaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Calderaro more than expected).

Fields of papers citing papers by Francesco Calderaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Calderaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Calderaro. The network helps show where Francesco Calderaro may publish in the future.

Co-authorship network of co-authors of Francesco Calderaro

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Calderaro. A scholar is included among the top collaborators of Francesco Calderaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Calderaro. Francesco Calderaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Adjunctive use of oral MAF is associated with no disease progression or mortality in hospitalized patients with COVID-19 pneumonia: The single-arm COral-MAF1 prospective trial 2023 ·Biomedicine & Pharmacotherapy ·(unknown), Marina Lugarà, (unknown), (unknown), Gabriella Oliva, (unknown), (unknown), Francesco Calderaro, (unknown), Pietro Hiram Guzzi, (unknown), (unknown), Roberta Marra, Maria Galdo, (unknown), Toshio Inui, (unknown), Giuseppe Vitiello, (unknown), Giuseppe Tortoriello	0
2	Successful Treatment of Iron Deficiency Anemia with Ferric Carboxymaltose in an Elderly Patient with Multiple Comorbidities and COVID-19 2021 ·Cureus ·(unknown), (unknown), Francesco Calderaro, (unknown)	1
3	A Triad of Ketoacidosis, Hypertriglyceridemia, and Acute Pancreatitis Associated With Sugar-Sweetened Soft Drinks Abuse in a Caucasian Patient With Undiagnosed Type 2 Diabetes Mellitus 2020 ·Cureus ·Alessandra Vitelli, (unknown), Francesco Calderaro, (unknown), (unknown)	5
4	Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments 2012 ·Journal of Cellular Biochemistry ·Silvia Palumbo, Luigi Pirtoli, Paolo Tini, Gabriele Cevenini, Francesco Calderaro, Marzia Toscano, Clelia Miracco, Sergio Comincini	61
5	Multicentre Evaluation of the Second Generation Elecsys NT-proBNP Assay 2008 ·(unknown), Ilaria Conti, Francesco Calderaro, Luisa Beltran, (unknown), (unknown), Hilmar Luthe, Simcha Meisel, Jordi Mercé, (unknown), (unknown), (unknown), Claudia Schulz, R. Tauber, (unknown), Jochen Jarausch, Mauro Panteghini	3
6	Additive Effects of Salmeterol and Fluticasone or Theophylline in COPD 2000 ·CHEST Journal ·Mario Cazzola, Gabriele Di Lorenzo, F. Di Perna, Francesco Calderaro, R. Testi, Stefano Centanni	59
7	Comparative Study of Dirithromycin and Azithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis 1999 ·Journal of Chemotherapy ·Mario Cazzola, Annamaria Vinciguerra, F. Di Perna, (unknown), Francesco Calderaro, Antonello Salzillo, Stefano Centanni	14
8	Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease 1999 ·European Journal of Clinical Pharmacology ·Mario Cazzola, Francesco Calderaro, (unknown), (unknown), Claudio F. Donner, (unknown), Maria Gabriella Matera	19
9	Cardiac Effects of Formoterol and Salmeterol in Patients Suffering from COPD with Preexisting Cardiac Arrhythmias and Hypoxemia 1998 ·CHEST Journal ·Mario Cazzola, Francesco Imperatore, Antonello Salzillo, F. Di Perna, Francesco Calderaro, (unknown), Maria Gabriella Matera	144
10	A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease 1998 ·Respiratory Medicine ·Mario Cazzola, Maria Gabriella Matera, F. Di Perna, Francesco Calderaro, (unknown), Annamaria Vinciguerra	26
11	Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD 1998 ·European Respiratory Journal ·Mario Cazzola, F. Di Perna, Paolo Noschese, Annamaria Vinciguerra, Francesco Calderaro, Giuseppe Girbino, Maria Gabriella Matera	35
12	A comparison of the bronchodilating effects of salmeterol, salbutamol and Ipratropium bromide in patients with chronic obstructive pulmonary disease 1995 ·Pulmonary Pharmacology ·Maria Gabriella Matera, Mario Cazzola, Annamaria Vinciguerra, F. Di Perna, Francesco Calderaro, M Caputi, F. Rossi	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact